Publication | Open Access

Discovery of novel thieno[2,3-d]pyrimidin-4-yl hydrazone-based inhibitors of Cyclin D1-CDK4: Synthesis, biological evaluation and structure–activity relationships. Part 2

Medicinal ChemistryBiochemistryPart 2MedicineNatural SciencesRational Drug DesignCyclin D1-cdk4PharmacotherapyStructure–activity RelationshipsDrug DevelopmentPharmacologyPharmaceutical ChemistryDrug Discovery